Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Payables (2019 - 2023)

Alx Oncology Holdings' Payables history spans 5 years, with the latest figure at $13.0 million for Q3 2023.

  • For Q3 2023, Payables rose 121.11% year-over-year to $13.0 million; the TTM value through Sep 2023 reached $13.0 million, up 121.11%, while the annual FY2022 figure was $8.1 million, 114.48% up from the prior year.
  • Payables for Q3 2023 was $13.0 million at Alx Oncology Holdings, up from $4.1 million in the prior quarter.
  • Across five years, Payables topped out at $13.0 million in Q3 2023 and bottomed at $4000.0 in Q4 2020.
  • The 5-year median for Payables is $5.1 million (2022), against an average of $5.5 million.
  • The largest annual shift saw Payables crashed 99.89% in 2020 before it soared 94000.0% in 2021.
  • A 5-year view of Payables shows it stood at $3.7 million in 2019, then plummeted by 99.89% to $4000.0 in 2020, then skyrocketed by 94000.0% to $3.8 million in 2021, then skyrocketed by 114.48% to $8.1 million in 2022, then surged by 61.04% to $13.0 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Payables are $13.0 million (Q3 2023), $4.1 million (Q2 2023), and $9.8 million (Q1 2023).